10/31/2024
7:09 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2024
7:50 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024
8:13 AM | Virax Biolabs Group (Filer)
| Form 424B5 | |
09/30/2024
8:14 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2024
7:54 AM | Virax Biolabs Group (Filer)
| Form 424B5 | |
08/23/2024
7:55 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024
3:24 PM | Virax Biolabs Group (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
08/01/2024
6:48 AM | Virax Biolabs Group (Filer)
| Form NT 20-F | |
04/25/2024
7:03 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024
6:34 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/15/2024
3:32 PM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2024
4:27 PM | Virax Biolabs Group (Filer)
| Form 424B5 | |
01/22/2024
4:28 PM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/12/2024
6:43 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/21/2023
6:34 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
3:12 PM | Virax Biolabs Group (Filer)
| Form 424B3 | |
12/18/2023
6:37 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2023
11:15 PM | Virax Biolabs Group (Filer)
| Form EFFECT | |
12/14/2023
6:43 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
5:03 AM | Virax Biolabs Group (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
